Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

Key facts

Where
Rochester, United StatesSee the site

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesContact: Anna PickTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Mayo Clinic
Trial code
NCT07604220
Record updated
17 August 2026
Original description
The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.Read full original descriptionShow less

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Inclusion: Adults ≥18 years; Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis; Undergoing FDG-PET as part of standard care; Ability to provide informed consent.

Exclusion: Inability to provide informed consent.

ClinicalTrials.gov NCT07604220